Form 8-K
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 15, 2010

ULTRALIFE CORPORATION
 (Exact name of registrant as specified in its charter)

         
Delaware   000-20852   16-1387013
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
2000 Technology Parkway, Newark, New York
   14513
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (315) 332-7100

 
 
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 15, 2010, Ultralife Corporation (the “Company”) received notice from Paula H.J. Cholmondeley that she had decided not to stand for re-election to the Board of Directors at the Company’s annual meeting of shareholders on June 8, 2010. Ms. Cholmondeley will complete her current term on the Board of Directors, which expires at the Company’s annual meeting of shareholders.

In accordance with the Company’s corporate governance principles, Anthony J. Cavanna will not stand for re-election to the Board of Directors at the Company’s annual meeting of shareholders because he has reached the mandatory retirement age of 70. Mr. Cavanna will complete his current term on the Board of Directors, which expires at the Company’s annual meeting of shareholders.

 

2

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
Date: March 3, 2010   ULTRALIFE CORPORATION
 
   
 
   /s/ Peter F. Comerford                      
 
   Peter F. Comerford
 
   Vice President of Administration
and General Counsel

 

3